SAFETY OF LURASIDONE IN SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RCTS WITH ACTIVE COMPARATORS

被引：0
|
作者：
Hagi, K. [1 ]
Nosaka, T. [1 ]
Pikalov, A. [2 ]
Loebel, A. [2 ]
Kane, J. [3 ]
机构：
[1] Sumitomo Dainippon Pharma Co Ltd, Med Affairs, Tokyo, Japan
[2] Sunov Pharmaceut Inc, Marlborough, MA USA
[3] North Shore Long Isl Jewish Hlth Syst, Psychiat Res, Zucker Hillside Hosp, New York, NY USA
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2017年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：151 / 152
页数：2
相关论文
共 50 条
  • [1] EFFICACY OF LURASIDONE IN SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RCTS WITH ACTIVE COMPARATORS
    Nosaka, T.
    Hagi, K.
    Pikalov, A.
    Loebel, A.
    Kane, J.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2017, 51 : 152 - 152
  • [2] Safety of lurasidone in schizophrenia: a systematic review and meta-analysis of short-term trials utilizing active comparator
    Hagi, K.
    Nosaka, T.
    Pikalov, A.
    Loebel, A.
    Kane, J. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S580 - S581
  • [3] Systematic literature review and network meta-analysis of lurasidone, brexpiprazole and cariprazine for schizophrenia
    Phalguni, Angaja
    McCool, Rachael
    Wood, Hannah
    Sanderson, Alice
    Rydevik, Gustaf
    Franklin, Brooke
    James, Daniel
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2023, 38 (01) : 45 - 56
  • [4] Efficacy of lurasidone in schizophrenia: a systematic review and meta-analysis of short-term trials utilizing active comparator
    Nosaka, T.
    Hagi, K.
    Pikalov, A.
    Loebel, A.
    Kane, J. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S580 - S580
  • [5] Safety of rTMS for Schizophrenia: A Systematic Review and Meta-analysis
    Blyth, Sophia H.
    Cruz Bosch, Claudia
    Raffoul, Julian J.
    Chesley, Jordyn
    Johnson, Benjamin
    Borodge, Darara
    Sagarwala, Raza
    Masters, Ross
    Brady Jr, Roscoe O.
    Vandekar, Simon
    Ward, Heather Burrell
    SCHIZOPHRENIA BULLETIN, 2024, 51 (02) : 392 - 400
  • [6] Efficacy, tolerability, and safety of lurasidone for acute schizophrenia: A systematic review and network meta-analysis of phase 3 trials in Japan
    Kishi, Taro
    Nosaka, Tadashi
    Sakuma, Kenji
    Okuya, Makoto
    Iwata, Nakao
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2020, 40 (03) : 314 - 322
  • [7] Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia
    Solmi, Marco
    Veronese, Nicola
    Thapa, Nita
    Facchini, Silvia
    Stubbs, Brendon
    Fornaro, Michele
    Carvalho, Andre F.
    Correll, Christoph U.
    CNS SPECTRUMS, 2017, 22 (05) : 415 - 426
  • [8] Efficacy of lurasidone versus placebo in schizophrenia: a systematic review and meta-analysis of randomized controlled studies
    Nosaka, T.
    Hagi, K.
    Pikalov, A.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S242 - S242
  • [9] Effectiveness and safety of Baduanjin for schizophrenia: A protocol for systematic review and meta-analysis
    Wu, Haiyuan
    Xue, Kaiyuan
    Peng, Aineng
    Chai, Jianbo
    Zhao, Yonghou
    MEDICINE, 2022, 101 (48) : E32007
  • [10] Preimplantation genetic screening: a systematic review and meta-analysis of RCTs
    Mastenbroek, S.
    Twisk, M.
    van der Veen, F.
    Repping, S.
    HUMAN REPRODUCTION UPDATE, 2011, 17 (04) : 454 - 466
12345